Devises / VSTM
VSTM: Verastem Inc
9.25
USD
0.02
(0.22%)
Le taux de change de VSTM a changé de 0.22% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 8.96 et à un maximum de 9.33.
Suivez la dynamique Verastem Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
VSTM Nouvelles
- Mizuho lowers Verastem stock price target to $14 on dilution from financing
- Verastem stock soars after KRAS inhibitor shows strong lung cancer results
- GFH375 shows 68.8% response rate in non-small cell lung cancer study
- Verastem (VSTM) Reports Q2 Loss, Misses Revenue Estimates
- Verastem CEO Paterson sells $7,738 in shares
- Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
- Earnings Preview: Verastem (VSTM) Q2 Earnings Expected to Decline
- FDA grants fast track designation to Verastem’s pancreatic cancer drug
- Verastem: The Market Is Ignoring The Progress (NASDAQ:VSTM)
- Verastem stock rises after LGSOC treatment data published in medical journal
- Verastem’s cancer drug shows 31% response rate in ovarian cancer trial
- Avutometinib-defactinib combo shows strong results in LGSOC patients
- Verastem: Approval Secured, Moving On To PDAC And KRAS G12D-Related Cancers
- Verastem CEO Paterson sells $1.8k in shares
- Verastem director Gagnon sells $1604 in shares
- Cantor Fitzgerald reiterates overweight rating on Verastem stock
- Meta and Biontech Lead Market Cap Stock Movers on Monday
- Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May - Applied Digital (NASDAQ:APLD), Lyra Therapeutics (NASDAQ:LYRA)
- What's Going On With Verastem Oncology Stock On Monday? - Verastem (NASDAQ:VSTM)
- Verastem reports promising cancer drug trial results
- TD Cowen maintains buy rating on Tempus AI stock after short report
- Verastem Oncology to Present at the Jefferies Global Healthcare Conference
- Verastem stock soars to 52-week high, hits $8.5
- Tempus AI shareholders approve key proposals at annual meeting
Range quotidien
8.96
9.33
Range Annuel
2.34
9.43
- Clôture Précédente
- 9.23
- Ouverture
- 9.26
- Bid
- 9.25
- Ask
- 9.55
- Plus Bas
- 8.96
- Plus Haut
- 9.33
- Volume
- 2.973 K
- Changement quotidien
- 0.22%
- Changement Mensuel
- 53.15%
- Changement à 6 Mois
- 63.72%
- Changement Annuel
- 272.98%
31 août, dimanche